Cargando…

Ferroptosis gene signature in cholangiocarcinoma

Detalles Bibliográficos
Autor principal:	Cingaram, Pradeep Reddy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647422/ https://www.ncbi.nlm.nih.gov/pubmed/36381654 http://dx.doi.org/10.1016/j.omto.2022.10.007

Ejemplares similares

The tRNA-derived fragment signature in lung cancer
por: Cingaram, Pradeep Reddy
Publicado: (2022)

A potential therapeutic approach for tauopathies
por: Cingaram, Pradeep Reddy
Publicado: (2022)

tRF-1001: A potential therapeutic target for ocular neovascular diseases
por: Cingaram, Pradeep Reddy
Publicado: (2023)

Epigenetic therapy: BBC1115, a novel BET inhibitor with broad antitumor activity
por: Cingaram, Pradeep Reddy
Publicado: (2023)

CRISPR-Cas9 in hiPSCs: A new era in personalized treatment for Stargardt disease
por: Kuntam, Soujanya, et al.
Publicado: (2023)

A Novel Ferroptosis-Related 4-Gene Prognostic Signature for Cholangiocarcinoma and Photodynamic Therapy
por: Zhang, Zi-jian, et al.
Publicado: (2021)

Exploration and validation of a novel ferroptosis-related gene signature predicting the prognosis of intrahepatic cholangiocarcinoma: Ferroptosis-related gene model for ICC
por: Yao, Xinfei, et al.
Publicado: (2022)

Identification and validation of a novel ferroptosis-related gene signature for prognosis and potential therapeutic target prediction in cholangiocarcinoma
por: Sae-fung, Apiwit, et al.
Publicado: (2023)

Ferroptosis as an important driver of lupus
por: Mao, Chao, et al.
Publicado: (2021)

ScRNA-seq and bulk RNA-seq reveal the characteristics of ferroptosis and establish a risk signature in cholangiocarcinoma
por: Yao, Wenchao, et al.
Publicado: (2022)

Ferroptosis vulnerability in MYCN‐driven neuroblastomas
por: Dasgupta, Shayani, et al.
Publicado: (2022)

An NADPH sensor that regulates cell ferroptosis
por: Kuang, Guixing, et al.
Publicado: (2022)

Ferroptosis: friend or foe in cancer immunotherapy?
por: Demuynck, Robin, et al.
Publicado: (2023)

Implication of Ferroptosis in Cholangiocarcinoma: A Potential Future Target?
por: Yang, Mingyu, et al.
Publicado: (2023)

How erastin assassinates cells by ferroptosis revealed
por: Gan, Boyi
Publicado: (2022)

Ferroptosis: the vulnerability within a cancer monster
por: Xie, Wanqing, et al.
Publicado: (2023)

LIF-ting ferroptosis to improve liver cancer therapy
por: Yao, Fan, et al.
Publicado: (2022)

Ferroptosis, a key to unravel the enigma of the FLASH effect?
por: Vilaplana-Lopera, Nuria, et al.
Publicado: (2022)

Ferroptosis in myocardial infarction: not a marker but a maker
por: Wang, Xiao-dong, et al.
Publicado: (2021)

Ferroptosis-related gene signatures in neuroblastoma associated with prognosis
por: Chen, Yiru, et al.
Publicado: (2022)

Connecting N6‐methyladenosine modification to ferroptosis resistance in hepatoblastoma
por: Peng, Wan‐Xin, et al.
Publicado: (2022)

Cytochrome P450 reductase (POR) as a ferroptosis fuel
por: Koppula, Pranavi, et al.
Publicado: (2021)

Predicting Treatment Outcomes: The Case for Hypoxia Gene Signatures
por: Marignol, Laure
Publicado: (2018)

Bioinformatics Analysis of Inflammation Gene Signature in Indicating Cholangiocarcinoma Prognosis
por: Wang, Yanting, et al.
Publicado: (2022)

Construction of a Novel Ferroptosis-Related Gene Signature of Atherosclerosis
por: Huang, Tucheng, et al.
Publicado: (2022)

Identification the ferroptosis-related gene signature in patients with esophageal adenocarcinoma
por: Zhu, Lei, et al.
Publicado: (2021)

Prognostic implications of ferroptosis-associated gene signature in colon adenocarcinoma
por: Miao, Yan-Dong, et al.
Publicado: (2021)

New Autophagy-Ferroptosis Gene Signature Predicts Survival in Glioma
por: Zhou, Liwei, et al.
Publicado: (2021)

Ferroptosis‐related gene signature predicts prognosis and immunotherapy in glioma
por: Wan, Rong‐Jun, et al.
Publicado: (2021)

Prion Protein Does Not Confer Resistance to Hippocampus-Derived Zpl Cells against the Toxic Effects of Cu(2+), Mn(2+), Zn(2+) and Co(2+) Not Supporting a General Protective Role for PrP in Transition Metal Induced Toxicity
por: Cingaram, Pradeep Kumar Reddy, et al.
Publicado: (2015)

Identification of immune related gene signature for predicting prognosis of cholangiocarcinoma patients
por: Zhang, Zi-jian, et al.
Publicado: (2023)

A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options
por: Criscuolo, Daniela, et al.
Publicado: (2022)

Construction and validation of a 15-gene ferroptosis signature in lung adenocarcinoma
por: Tu, Guangxu, et al.
Publicado: (2021)

Clinical and Biological Significances of a Ferroptosis-Related Gene Signature in Glioma
por: Zhuo, Shenghua, et al.
Publicado: (2020)

Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma
por: Shi, Jinyuan, et al.
Publicado: (2021)

Identification and validation of ferroptosis-related gene signature in intervertebral disc degeneration
por: Xiang, Qian, et al.
Publicado: (2023)

A novel 25-ferroptosis-related gene signature for the prognosis of gliomas
por: Peng, Xiaojiang, et al.
Publicado: (2023)

Predicting prognosis of breast cancer with gene signatures: are we lost in a sea of data?
por: Iwamoto, Takayuki, et al.
Publicado: (2010)

Selected Patients with Unresectable Perihilar Cholangiocarcinoma (pCCA) Derive Long-Term Benefit from Liver Transplantation
por: Azad, Adiba I., et al.
Publicado: (2020)

Isocitrate dehydrogenase 1 mutation in cholangiocarcinoma impairs tumor progression by sensitizing cells to ferroptosis
por: Su, Li, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_reueeiebquslm7tp7h8uba047c